Tandem Mass Spectrometry Has a Larger Analytical Range than Fluorescence Assays of Lysosomal Enzymes: Application to Newborn Screening and Diagnosis of Mucopolysaccharidoses Types II, IVA, and VI.
about
Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease.Enzyme activities of α-glucosidase in Japanese neonates with pseudodeficiency allelesNewborn Screening for Lysosomal Storage Diseases: A Concise Review of the Literature on Screening Methods, Therapeutic Possibilities and Regional ProgramsFluorimetric assays for N-acetylgalactosamine-6-sulfatase and arylsulfatase B based on the natural substrates for confirmation of mucopolysaccharidoses types IVA and VILevels of enzyme activities in six lysosomal storage diseases in Japanese neonates determined by liquid chromatography-tandem mass spectrometryBio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study.Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs.Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe Disease.Quantification of the enzyme activities of iduronate-2-sulfatase, N-acetylgalactosamine-6-sulfatase and N-acetylgalactosamine-4-sulfatase using liquid chromatography-tandem mass spectrometry.Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.Multiplex Tandem Mass Spectrometry Enzymatic Activity Assay for Newborn Screening of the Mucopolysaccharidoses and Type 2 Neuronal Ceroid Lipofuscinosis.Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.Quantification of 11 enzyme activities of lysosomal storage disorders using liquid chromatography-tandem mass spectrometry
P2860
Q33626787-47EE97C1-0BE6-4BEC-9BED-CC0D17E73206Q33889736-76D38F06-82D3-421C-908D-1C74B3477546Q33915327-3EF0F6CE-02A1-4BDA-B8AC-104F9CE43C4FQ36307595-752413F8-19DE-4833-B904-8FDA1F2C2215Q37231652-9DCF144F-1487-49B2-AB7D-643AA6D039CBQ39436172-588292FC-8A43-448B-9A06-2D57453BCE2DQ40378119-63AD2EC4-8E37-4DDA-932D-399282AD5530Q42200983-9FA1D796-5B82-4FDC-8DD5-601E4A4ED6F9Q45874778-605F8D79-22A6-4103-BD89-E4CEE7324919Q47904372-2EB0599E-94A7-400E-9593-EC5CBD312E11Q49406849-A0436652-4EB5-4FA8-AE70-94BA1F506798Q49977306-A4671531-EB1A-4E67-BBEE-273DC740893EQ50712687-DF8CA170-6966-4393-9AA6-788E10162965Q55074307-B68CC745-A5ED-4AD6-BB5C-D729C784D7DAQ58759482-3267DC3B-87C0-4027-B889-49A5ED18FBDB
P2860
Tandem Mass Spectrometry Has a Larger Analytical Range than Fluorescence Assays of Lysosomal Enzymes: Application to Newborn Screening and Diagnosis of Mucopolysaccharidoses Types II, IVA, and VI.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tandem Mass Spectrometry Has a ...... ridoses Types II, IVA, and VI.
@ast
Tandem Mass Spectrometry Has a ...... ridoses Types II, IVA, and VI.
@en
type
label
Tandem Mass Spectrometry Has a ...... ridoses Types II, IVA, and VI.
@ast
Tandem Mass Spectrometry Has a ...... ridoses Types II, IVA, and VI.
@en
prefLabel
Tandem Mass Spectrometry Has a ...... ridoses Types II, IVA, and VI.
@ast
Tandem Mass Spectrometry Has a ...... ridoses Types II, IVA, and VI.
@en
P2093
P2860
P1433
P1476
Tandem Mass Spectrometry Has a ...... aridoses Types II, IVA, and VI
@en
P2093
Arun Babu Kumar
C Ronald Scott
Farideh Ghomashchi
Frantisek Turecek
Makoto Ito
Michael H Gelb
Naveen Kumar Chennamaneni
Sophia Masi
P2860
P304
P356
10.1373/CLINCHEM.2015.242560
P407
P577
2015-09-14T00:00:00Z